|Articles|December 7, 2022

Suvoda Launches eCOA-Specific Language and Design Toolkit

Functionality seeks to alleviate eCOA burdens, reduce time-to-launch, and improve site, clinician, and patient experience.

Suvoda announced that as part of its single platform rollout, its eCOA solution is moving to the second phase of the Early Adopter program. This solution, designed to work with Suvoda IRT and eConsent, focuses on addressing eCOA challeneges such as gaps in overall delivery and execution quality, time consuming translations and localization processes, and logistics related to device management.

Read more about the solution here.


Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Related Content